Methods and reagents for the treatment of immunoinflammatory disorders
US8080553B2 · kind B2 · utility
54Cited by
54References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2006 |
| Grant date | Dec 20, 2011 |
| Priority date | — |
| Expiry date | Oct 20, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/209
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.